NOVT Stock Overview
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$164.94 |
| 52 Week High | US$187.12 |
| 52 Week Low | US$142.35 |
| Beta | 1.29 |
| 11 Month Change | -5.76% |
| 3 Month Change | -8.66% |
| 1 Year Change | 14.32% |
| 33 Year Change | -3.36% |
| 5 Year Change | 76.26% |
| Change since IPO | 934.91% |
Recent News & Updates
Recent updates
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital
Oct 15
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S
Sep 12Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold
Sep 02Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?
Aug 24Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price
Aug 02Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively
Jun 22Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)
May 08Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 24Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely
Dec 29Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching
Nov 20Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Nov 01Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?
Oct 19Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly
Sep 21Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing
Sep 06What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?
Aug 19Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Jul 16Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement
Jun 06These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well
May 16Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?
Apr 13Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Mar 29Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)
Feb 27These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely
Feb 12Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?
Jan 12We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease
Dec 28Is Novanta (NASDAQ:NOVT) Using Too Much Debt?
Nov 02What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?
Oct 03With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case
Sep 19Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Aug 23Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance
Aug 09Novanta (NASDAQ:NOVT) Could Easily Take On More Debt
Aug 03Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return
Jul 11Shareholder Returns
| NOVT | US Electronic | US Market | |
|---|---|---|---|
| 7D | -3.1% | -1.9% | -1.0% |
| 1Y | 14.3% | 29.9% | 30.3% |
Return vs Industry: NOVT underperformed the US Electronic industry which returned 28.7% over the past year.
Return vs Market: NOVT underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| NOVT volatility | |
|---|---|
| NOVT Average Weekly Movement | 4.8% |
| Electronic Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NOVT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NOVT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| NOVT fundamental statistics | |
|---|---|
| Market cap | US$5.95b |
| Earnings (TTM) | US$60.13m |
| Revenue (TTM) | US$922.75m |
98.5x
P/E Ratio6.4x
P/S RatioIs NOVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOVT income statement (TTM) | |
|---|---|
| Revenue | US$922.75m |
| Cost of Revenue | US$517.88m |
| Gross Profit | US$404.88m |
| Other Expenses | US$344.74m |
| Earnings | US$60.13m |
Last Reported Earnings
Sep 27, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.67 |
| Gross Margin | 43.88% |
| Net Profit Margin | 6.52% |
| Debt/Equity Ratio | 61.6% |
How did NOVT perform over the long term?
See historical performance and comparison